- Home
- IPDN vs EVAX Comparison
IPDN vs EVAX Comparison
Compare IPDN & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPDN
- EVAX
- Stock Information
- Founded
- IPDN 2003
- EVAX 2008
- Country
- IPDN United States
- EVAX Denmark
- Employees
- IPDN N/A
- EVAX N/A
- Industry
- IPDN EDP Services
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IPDN Technology
- EVAX Health Care
- Exchange
- IPDN Nasdaq
- EVAX Nasdaq
- Market Cap
- IPDN 10.2M
- EVAX 8.7M
- IPO Year
- IPDN 2013
- EVAX 2021
- Fundamental
- Price
- IPDN $0.48
- EVAX $0.88
- Analyst Decision
- IPDN
- EVAX Strong Buy
- Analyst Count
- IPDN 0
- EVAX 2
- Target Price
- IPDN N/A
- EVAX $11.00
- AVG Volume (30 Days)
- IPDN 30.5K
- EVAX 77.4K
- Earning Date
- IPDN 11-14-2024
- EVAX 10-31-2024
- Dividend Yield
- IPDN N/A
- EVAX N/A
- EPS Growth
- IPDN N/A
- EVAX N/A
- EPS
- IPDN N/A
- EVAX N/A
- Revenue
- IPDN $7,005,632.00
- EVAX $3,295,000.00
- Revenue This Year
- IPDN N/A
- EVAX $4,845.21
- Revenue Next Year
- IPDN N/A
- EVAX $30.30
- P/E Ratio
- IPDN N/A
- EVAX N/A
- Revenue Growth
- IPDN N/A
- EVAX N/A
- 52 Week Low
- IPDN $0.42
- EVAX $0.87
- 52 Week High
- IPDN $3.01
- EVAX $13.61
- Technical
- Relative Strength Index (RSI)
- IPDN 29.41
- EVAX 19.35
- Support Level
- IPDN $0.48
- EVAX $1.08
- Resistance Level
- IPDN $0.62
- EVAX $1.20
- Average True Range (ATR)
- IPDN 0.06
- EVAX 0.18
- MACD
- IPDN -0.02
- EVAX -0.01
- Stochastic Oscillator
- IPDN 0.97
- EVAX 1.11
About IPDN Professional Diversity Network Inc.
Professional Diversity Network Inc is engaged in providing access to networking, training, educational and employment services to its registered users. It has three operating segments: the Professional Diversity Network (PDN) segment, which includes online professional networking communities with career resources for diverse cultural groups and employers looking to hire members; and the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization, the RemoteMore segment. The company generates majority of its revenue from PDN Segment.
About EVAX Evaxion Biotech A/S
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.